Solu-cortef and Haldol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Solu-cortef (hydrocortisone sodium succinate) and Haldol (haloperidol). Common drug interactions include anaemia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Solu-cortef and Haldol. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

What is Haldol?

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 23,102 Haldol users. Check the latest studies of Haldol.

On Jul, 19, 2026

25 people who take Solu-cortef and Haldol together, and have interactions are studied.

Solu-cortef and Haldol drug interactions.

What are the common drug interactions of Solu-Cortef and Haldol, by gender? *:

female:

Anaemia (lack of blood)
Sedation
Haemoglobin decreased
Death
Electrocardiogram qt prolonged
Increased appetite
Respiratory depression (respiration has a rate below 12 breaths)
Agitation (state of anxiety or nervous excitement)
Anxiety
Aspartate aminotransferase increased

male:

Febrile neutropenia (fever with reduced white blood cells)
Pemphigoid (tense blisters on the skin)
Ataxia (loss of full control of bodily movements)
Blood bilirubin increased
Blood lactate dehydrogenase increased
Cardiac failure
Coma (state of unconsciousness lasting more than six hours)
Death
Depressed level of consciousness
Echolalia (meaningless repetition of another person's spoken words -psychiatric disorder)

What are the common drug interactions of Solu-Cortef and Haldol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Death
Electrocardiogram qt prolonged
Increased appetite
Respiratory depression (respiration has a rate below 12 breaths)
Sedation
Abdominal pain
Agitation (state of anxiety or nervous excitement)
Amaurosis (partial or total blindness without visible change in the eye)
Aphasia (damage to the parts of the brain that control language)
Ataxia (loss of full control of bodily movements)

10-19:

Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)
Anxiety
Aspartate aminotransferase increased
Blood bilirubin increased
Cough
Decreased appetite
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Haemoglobin decreased

20-29:

n/a

30-39:

Pharyngitis (inflammation of the pharynx, causing a sore throat)

40-49:

Anaemia (lack of blood)
Hypertension (high blood pressure)
Post procedural haemorrhage (post procedural bleeding)
Pseudocyst (pathological collection of fluid)
Thrombocytopenia (decrease of platelets in blood)
Ascites (accumulation of fluid in the abdominal cavity)
Hepatic failure (liver failure)
Intra-abdominal haemorrhage (intra-abdominal bleeding)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Pancreatitis acute (sudden inflammation of pancreas)

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Pemphigoid (tense blisters on the skin)
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Haematocrit decreased
Haemodynamic instability (disturbances in the blood movement in our body)
Haemoglobin decreased
Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
Multi-organ failure (multisystem organ failure)

60+:

Adverse drug reaction
Alanine aminotransferase increased
Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
Neutropenia (an abnormally low number of neutrophils)
Post procedural haemorrhage (post procedural bleeding)
Respiratory distress (difficulty in breathing)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
White blood cell count decreased
Aspartate aminotransferase increased

What are the existing conditions these people have? *

Constipation: 4 people, 16.00%
Nausea (feeling of having an urge to vomit): 4 people, 16.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 12.00%
Fever: 3 people, 12.00%
High Blood Cholesterol: 3 people, 12.00%
Stress And Anxiety: 3 people, 12.00%
Tumor: 2 people, 8.00%
Hoarseness Or Changing Voice: 2 people, 8.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 8.00%
Back Pain: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and Haldol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously